Clinical Trial

BRIEF COGNITIVE and DELIRIUM ASSESSMENTS in STROKE PATIENTS

Study acronym: COGISTROKE
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated May 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the project is to validate the ALBA and PICNIR tests for the easy detection of memory and speech disorders in patients after a stroke. Patients, after their first stroke, with the possibility of initial clinical evaluation within 24 hours of admission to the Neurology Clinic ICU, will undergo a neurological examination, cognitive tests using the ALBA and PICNIR tests, delirium tests using the CAM-ICU and ICDSC tools, and a speech therapy test using the MASTcz tool. If possible, these will be conducted simultaneously in one half-day. A similar structured examination will take place within five days, with a tolerance of one day. Upon demonstrating utility, doctors will be able to utilize the very brief ALBA and POBAV methods for detecting memory and speech disorders in post-stroke patients in clinical practice.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06670716
Lead Sponsor Faculty Hospital Kralovske Vinohrady
Conditions Stroke Acute
Enrollment 60 participants
Start Date 2024-04-03
Primary Completion 2025-05-03 (estimated)
Study Completion 2026-05-03 (estimated)
Updated on ClinicalTrials.gov 2025-02-25